199 results
-
List item
Human medicine European public assessment report (EPAR): Integrilin
eptifibatide, Angina, Unstable; Myocardial Infarction
Date of authorisation: 01/07/1999, Revision: 26, Authorised, Last updated: 17/03/2022Integrilin Cardiovascular Diseases Heart … part of the EPAR). What is Integrilin? Integrilin is a medicine that contains … solution for injection. What is Integrilin used for Integrilin is used to prevent a myocardial … -
List item
Human medicine European public assessment report (EPAR): Eptifibatide Accord
eptifibatide, Myocardial Infarction
Date of authorisation: 11/01/2016,
, Revision: 6, Authorised, Last updated: 21/04/2023
European Union (EU) called Integrilin. How is Eptifibatide Accord … as the reference medicine, Integrilin. What are the benefits and … shown to be comparable to Integrilin. Therefore, the Committee … -
List item
National expert: Paolo Porcelli, Italian Medicines Agency (updated)
- Declaration of interests - 39.21 KB | PDF
- Curriculum Vitae - 41.49 KB | PDF
“La valutazione dell’uso e della sicurezza dei farmaci … -
List item
National expert: Eraldo Donnarumma, Italian Medicines Agency (updated)
- Declaration of interests - 39.3 KB | PDF
- Curriculum Vitae - 25.83 KB | PDF
PANORAMI E PERCORSI) “Doping: soluzione o inganno chimico? (BIF n.4/2006 … PERCORSI) “Il corretto uso delle erbe medicinali” … -
List item
Veterinary medicine European public assessment report (EPAR): Convenia
cefovecin (as sodium salt), Dogs; Cats
Date of authorisation: 19/06/2006, Revision: 13, Authorised, Last updated: 08/12/2020Usobacterium … -
List item
Direct healthcare professional communications
Last updated: 14/02/2020 -
List item
National expert: Maria da Graca Ribeiro Campos, National Authority Of Medicines And Health Products (updated)
- Declaration of interests - 39.36 KB | PDF
- Curriculum Vitae - 240.74 KB | PDF
-
List item
National expert: Raffaella Sardelli, Italian Medicines Agency (updated)
- Declaration of interests - 39.64 KB | PDF
- Curriculum Vitae - 31.8 KB | PDF
“Contaminazione da alluminio in soluzioni di albumina umana: un monitoraggio … dell’attivatore della precallicreina in soluzioni di albumina umana” (Abs … -
List item
National expert: Emilia Cercenado Mansilla, The Spanish Agency Of Medicines And Medical Devices (updated)
- Declaration of interests - 41.48 KB | PDF
- Curriculum Vitae - 468.19 KB | PDF
-
List item
National expert: Giuseppina Ialongo, Italian Medicines Agency (updated)
- Declaration of interests - 39.2 KB | PDF
- Curriculum Vitae - 58.25 KB | PDF
Roma Aprile 1998, Seminario Interno U. O. Gruppo Grandi Rischi … -
List item
Human medicine European public assessment report (EPAR): Fampyra
Fampridine, Multiple Sclerosis
Date of authorisation: 20/07/2011, Revision: 16, Authorised, Last updated: 05/05/2022 -
List item
National expert: Francesca Rocchi, Italian Medicines Agency (updated)
- Declaration of interests - 41.46 KB | PDF
- Curriculum Vitae - 59.71 KB | PDF
-
List item
National expert: Antonio Portolés, The Spanish Agency Of Medicines And Medical Devices (updated)
- Declaration of interests - 44.48 KB | PDF
- Curriculum Vitae - 54.67 KB | PDF
-
List item
Human medicine European public assessment report (EPAR): Bavencio
avelumab, Neuroendocrine Tumors
Date of authorisation: 18/09/2017,
, Revision: 15, Authorised, Last updated: 24/03/2023
-
List item
National expert: Maria Jose Otero Lopez, European Medicines Agency (updated)
- Declaration of interests - 39.88 KB | PDF
- Curriculum Vitae - 32.45 KB | PDF
coordinator). Recomendaciones para el Uso Seguro del Potasio Intravenoso … SENSAR) e Instituto para el Uso Seguro de los Medicamentos … -
List item
National expert: Henrique Ramos da Costa, Directorate General For Food And Veterinary (updated)
- Declaration of interests - 39.92 KB | PDF
- Curriculum Vitae - 25.2 KB | PDF
medicamentos e outros produtos de uso veterinário: Sistema Nacional … medicamentos e outros produtos de uso veterinário: Sistema Nacional … medicamentos e outros produtos de uso veterinário: Sistema Nacional … -
List item
Human medicine European public assessment report (EPAR): Kengrexal
cangrelor, Acute Coronary Syndrome; Vascular Surgical Procedures
Date of authorisation: 23/03/2015,, Revision: 15, Authorised, Last updated: 16/01/2023
-
List item
National expert: Edurne Lazaro, The Spanish Agency Of Medicines And Medical Devices (updated)
- Declaration of interests - 39.31 KB | PDF
- Curriculum Vitae - 30.61 KB | PDF
Farmacovigilancia de medicamentos de Uso Humano. FEDRA: La base de … Farmacovigilancia de Medicamentos de Uso Humano. M Madurga, E. Lázaro … Farmacovigilancia de medicamentos de Uso Humano. Sistema Español … -
List item
Human medicine European public assessment report (EPAR): Cinryze
C1 inhibitor (human), Angioedemas, Hereditary
Date of authorisation: 15/06/2011,, Revision: 23, Authorised, Last updated: 10/10/2022
-
List item
National expert: Juana de la Torre Aboki, European Medicines Agency (updated)
- Declaration of interests - 40.6 KB | PDF
- Curriculum Vitae - 36.08 KB | PDF
posicionamiento sobre el uso del metotrexato parenteral … Castellanos_Moreira, Jacqueline Uson, Esperanza Naredo, Terence … -
List item
National expert: Juan Jose García Vieitez, The Spanish Agency Of Medicines And Medical Devices (updated)
- Declaration of interests - 39.68 KB | PDF
- Curriculum Vitae - 30.88 KB | PDF
-
List item
Human medicine European public assessment report (EPAR): Eladynos (updated)
abaloparatide, Osteoporosis, Postmenopausal; Osteoporosis, Revision: 1, Authorised, Last updated: 22/05/2023
-
List item
Veterinary medicine European public assessment report (EPAR): Evant
Eimeria acervulina, strain 003, Eimeria maxima, strain 013, Eimeria mitis, strain 006, Eimeria praecox, strain 007, Eimeria tenella, strain 004, Chicken
Date of authorisation: 05/02/2019, Revision: 1, Authorised, Last updated: 04/03/2022 -
List item
Human medicine European public assessment report (EPAR): Rinvoq
upadacitinib, Arthritis, Rheumatoid
Date of authorisation: 16/12/2019,
, , Revision: 14, Authorised, Last updated: 24/04/2023
-
List item
Human medicine European public assessment report (EPAR): Brintellix
Vortioxetine, Depressive Disorder, Major
Date of authorisation: 18/12/2013, Revision: 21, Authorised, Last updated: 31/03/2023